Dr Rachel Pearson JJ Wyatt
| Verification imaging in prostate MR-only radiotherapy: Are fiducial markers necessary? | 2025 |
|
JJ Wyatt Dr Rachel Pearson Dr George Petrides Dr Hazel McCallum Dr Ross Maxwell et al. | Evaluating a radiotherapy deep learning synthetic CT algorithm for PET-MR attenuation correction in the pelvis | 2024 |
|
JJ Wyatt Dr George Petrides Dr Rachel Pearson Dr Hazel McCallum Dr Ross Maxwell et al. | Impact of attenuation correction of radiotherapy hardware for positron emission tomography-magnetic resonance in ano-rectal radiotherapy patients | 2024 |
|
Nick West Dr Rachel Pearson
| Multi-institutional evaluation of a Pareto navigation guided automated radiotherapy planning solution for prostate cancer | 2024 |
|
Dr Rachel Pearson Dr Ross Maxwell JJ Wyatt Dr Hazel McCallum
| Comprehensive deep learning-based framework for automatic organs-at-risk segmentation in head-and-neck and pelvis for MR-guided radiation therapy planning | 2023 |
|
JJ Wyatt Dr Rachel Pearson Dr Ross Maxwell Dr Hazel McCallum
| Comprehensive dose evaluation of a Deep Learning based synthetic Computed Tomography algorithm for pelvic Magnetic Resonance-only radiotherapy | 2023 |
|
JJ Wyatt Dr Rachel Pearson Dr Sophie West Dr Hazel McCallum
| The first patients treated with MR-CBCT soft-tissue matching in a MR-only prostate radiotherapy pathway | 2023 |
|
Dr Hazel McCallum Dr Rachel Pearson JJ Wyatt
| Are cone beam CT image matching skills transferrable from planning CT to planning MRI for MR-only prostate radiotherapy? | 2021 |
|
JJ Wyatt Dr Rachel Pearson Chris Walker Dr Hazel McCallum
| Cone beam computed tomography for dose calculation quality assurance for magnetic resonance-only radiotherapy | 2021 |
|
Dr Rachel Pearson JJ Wyatt Dr Hazel McCallum
| Magnetic Resonance-only Workflow: Implementation in a UK Centre | 2020 |
|
Dr Rachel Pearson Dr Ashraf Azzabi
| Optimising Radium 223 Therapy for Metastatic Castration-Resistant Prostate Cancer –5-year Real-World Outcome: Focusing on Treatment Sequence and Quality of Life | 2020 |
|
JJ Wyatt Dr Rachel Pearson
| The accuracy of Magnetic Resonance – Cone Beam Computed Tomography soft-tissue matching for prostate radiotherapy | 2019 |
|
Dr Hans Sathasivam Benjamin Cosway Professor Vinidh Paleri Matt Kennedy Dr Rachel Pearson et al. | Clinicopathological features of squamous cell carcinoma of the oral cavity and oropharynx in young patients | 2018 |
|
Dr Charles Kelly Dr Hazel McCallum Dr Rachel Pearson
| Guidelines & recommendations: UK quantitative WB-DWI technical workgroup: Consensus meeting recommendations on optimisation, quality control, processing and analysis of quantitative whole-body diffusion-weighted imaging for cancer | 2018 |
|
Dr Rachel Pearson Professor Peter Thelwall Jim Snell Dr Piotr Pieniazek Professor Rakesh Heer et al. | Evaluation of early response to neoadjuvant chemotherapy in muscle-invasive bladder cancer using dynamic contrast-enhanced MRI and diffusion weighted MRI: MARBLE study | 2016 |
|
Dr Rachel Pearson Professor Peter Thelwall Jim Snell Dr Piotr Pieniazek Professor Rakesh Heer et al. | Evaluation of early responses to neoadjuvant chemotherapy in muscle-invasive bladder cancer using a dynamic contrast-enhanced MRI and diffusion-weighted MRI: MARBLE study | 2016 |
|
Dr Rachel Pearson
| Improving Staging in Bladder Cancer: The Increasing Role of Multiparametric Magnetic Resonance Imaging | 2016 |
|
Dr Rachel Pearson Elizabeth Howell Dr Kate Sumpter
| 3 '-Deoxy-3 '-18F-fluorothymidine positron emission tomography as an early predictor of disease progression in patients with advanced and metastatic pancreatic cancer | 2015 |
|
Bojidar Goranov Dr Yvette Drew Jonathon Graham Dr Rachel Pearson
| Academic opportunities within clinical oncology training | 2013 |
|
Dr Rachel Pearson Dr Sanjoy Chatterjee
| Correlation of HPV Status to Treatment Outcomes Post Radiotherapy in Tonsillar Carcinoma: a UK Regional Centre Experience [abstract] | 2011 |
|